Author:
Waumans Ruth C.,Muntingh Anna D. T.,Batelaan Neeltje M.,van Balkom Anton J. L. M.
Abstract
Dropout from psychological or pharmacological treatment for anxiety and depressive disorders is common. It is especially problematic in adolescents and young adults because of the adverse consequences for their development. Reasons for treatment dropout can be divided into therapy-process related factors, attitudinal aspects, and practical issues. Adjusting treatment to patient preferences and shared decision making, improving the therapeutic alliance, and interventions such as (family) psychoeducation, motivational interviewing, and help with practical issues are promising strategies to optimize engagement and adherence.
Subject
Psychiatry and Mental health
Reference46 articles.
1. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States;Kessler;Int J Methods Psychiatr Res,2012
2. Mental health in Dutch adolescents: a TRAILS report on prevalence, severity, age of onset, continuity and co-morbidity of DSM disorders;Ormel;Psychol Med,2015
3. Prevalence and stability of mental disorders among young adults: findings from a longitudinal study;Gustavson;BMC Psychiatry,2018
4. Longitudinal associations between depressive problems, academic performance, and social functioning in adolescent boys and girls;Verboom;Dev Psychol,2014
5. Social consequences of psychiatric disorders, I: educational attainment;Kessler;Am J Psychiatry,1995